Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Christian Rohlff0
Alasdair Stamps0
Jonathan Alexander Terrett0
Date of Patent
January 5, 2016
Patent Application Number
13823999
Date Filed
October 3, 2011
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention provides antibodies which bind to the extracellular domain of the Tyrosine-protein kinase transmembrane receptor ROR1. Nucleic acid molecules encoding the antibodies, expression vectors, host cells and methods for expressing the antibodies are also provided. The antibodies may be used for the treatment of cancer, including non-small cell lung carcinoma, B-cell chronic lymphocytic leukemia and colon cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.